Intellia Therapeutics Secures Up to $400 Million OrbiMed Debt Facility

Intellia Therapeutics (Nasdaq: NTLA) has secured a senior secured term loan facility of up to $400 million from OrbiMed, giving... Read More

The post Intellia Therapeutics Secures Up to $400 Million OrbiMed Debt Facility appeared first on citybiz.